Rubraca Tablet, Film Coated
Product Images NDC 82154-0784

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rubraca (NDC 82154-0784). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharmaand Gmbh, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp 200 mg (200 mg Spl)

The image shows a label for Rubraca (rucaparib) tablets, film coated, with a strength of 200 mg. The label indicates a package containing 60 tablets and specifies that the product is for prescription use only (Rx only). It includes storage instructions, distributor information for pharmaand GmbH in Vienna, Austria, and states the product is made in Switzerland. The label includes the NDC number 82154-0783-1 and a barcode.*

FDA Label Image

Pdp 250 mg (250 mg Spl)

Rubraca 250 mg tablets packaging label showing film-coated oral tablets. The label indicates 60 tablets in the package, prescription-only status, and storage instructions at 20°C to 25°C. The product is distributed by 2r pharma& GmbH, based in Vienna, Austria, and made in Switzerland. The label includes a barcode and NDC 82154-0784-1.*

FDA Label Image

Pdp 300 mg (300 mg Spl)

Rubraca 300 mg tablets label by pharmaand GmbH. The label includes dosage strength (300 mg), quantity (60 tablets), and prescribing info (Rx only). It states the product is made in Switzerland, distributed by zr pharma& GmbH in Vienna, Austria, and contains rucaparib camsylate equivalent to 300 mg rucaparib. Storage conditions are 20°C to 25°C with permitted excursions.*

FDA Label Image

Structural Formula (Rub01 0018 01)

Chemical structure of rucaparib, the active ingredient in Rubraca, showing its molecular framework with characteristic ring systems and functional groups.*

FDA Label Image

Figure 1 (Rub01 0018 02)

A Kaplan-Meier survival curve graph showing the probability of an event over time in months for two groups: Rubraca and placebo. The x-axis represents months from 0 to 36, and the y-axis represents probability from 0 to 1. The graph includes numbers at risk and events below the x-axis for both groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.